# POMBILITI
> **BLA761204** · Biologics License Application · Sponsor: AMICUS THERAP US · Approved 2023-09-28
## Drug
- **FDA Application Number:** BLA761204
- **Application type:** Biologics License Application
- **Brand name:** POMBILITI
- **Generic name:** CIPAGLUCOSIDASE ALFA-ATGA
- **Active ingredients:** CIPAGLUCOSIDASE ALFA-ATGA
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMICUS THERAP US
- **Manufacturer:** AMICUS THERAPEUTICS US, LLC
- **First approval:** 2023-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761204)
---
*AI Analytics · CC0 1.0*